In addition, a novel approach based on the depletion of TCR α/β+ T cells and B cells in which fresh alloreactive NK cells are infused together with CD34+ cells supports the notion that also fresh NK cells may represent suitable effectors against leukemia. This evidence concerns the gene CD34 and leukemia.